MedPath

DESIPRAMINE HYDROCHLORIDE

Desipramine Hydrochloride Tablets, USP

Approved
Approval ID

9c8f89b0-5da1-42ca-a3dd-b81f6d4e7a73

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2021

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

desipramine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-1021
Application NumberANDA207433
Product Classification
M
Marketing Category
C73584
G
Generic Name
desipramine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 9, 2021
FDA Product Classification

INGREDIENTS (9)

DESIPRAMINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: 1Y58DO4MY1
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DESIPRAMINE HYDROCHLORIDE - FDA Drug Approval Details